February 1, 2018 5:27pm

Sector intelligence and perspective

 

… It didn’t as the sector opened negative, stayed negative at the mid-day and closed to the downside

While the IBB (-0.09%) and the NASDAQ (-0.35%) were down; the XBI (+0.26%), XLV (+0.03%), IWM (+0.32%) jumped with the VIX plunging -0.52%

 

Don’t blame algorithms, sentiment rests with the differentiation and perception of platforms to investors enhanced by the lack of expectation fulfillment

The investor “well” is only so deep; appreciation could be drawn up by “buckets” of expectation fulfillment

 

Pre-open indications: 2 hits and 3 miss (1 by pennies)

 

Out and about: Gene therapy companies continued to dive with some exceptions after yesterday’s plunge due to possible risks of high systemic dosing of AAV – the players … AGTC (-$0.40), BOLD ($0.00), AVXS (-$4.96), RGNX (-$0.90) and QURE (-$0.02) while ADVM (+$0.40), ONCE (+$0.25), BLUE (+$0.35) gained altitude.

The Biostage (BSTG +$0.01) chronicles … don’t be fooled by surges of day trading after 20 M shares were reversed and past shareholders were “fleeced” in MY opinion!


Members only. Please login.